Sponsors (2)
This bill improves coordination, procurement discipline, and external oversight to strengthen biodetection capabilities through DOE partnerships and clearer acquisition rules, but does so at added cost and under tight deadlines that may divert resources and limit stakeholder engagement.
Local and state governments (and the general public) gain a coordinated plan to access DOE laboratory expertise for biodetection R&D, improving detection capabilities and potentially speeding identification of biological threats.
Local and state governments and federal implementers get procurement requirements aligned with the Federal Acquisition Regulation and DHS directives, which should streamline lawful acquisition and deployment of biodetection technologies in BioWatch jurisdictions.
Local and state governments and taxpayers benefit from mandated periodic external evaluations that identify gaps and recommend contingencies, increasing transparency and reliability of biodetection systems.
Taxpayers, local and state governments face higher costs because assessments, mandated procurement planning, external evaluations, and new biodetection technology acquisition and maintenance will require additional funding.
Federal employees and taxpayers may see DHS staff time and agency resources diverted to conduct assessments and implement the plan, reducing resources available for other DHS programs or priorities.
State and local governments, and partner institutions may have limited opportunity for full stakeholder engagement because tight statutory deadlines (180 days and 1 year) risk rushed or incomplete strategies and implementation challenges.
Based on analysis of 2 sections of legislative text.
Requires the Secretary of Homeland Security to assess how DHS has used Department of Energy national laboratories and sites for biodetection research and development, and to deliver a coordinated strategy for working with those labs to meet DHS biodetection needs. The Secretary must submit the assessment and a strategy within 180 days and provide a follow-up update within one year describing implementation challenges. The strategy must identify key biodetection technologies informed by DHS capability reviews and oversight studies, include a procurement plan that follows federal acquisition rules, require periodic external performance evaluations with contingency recommendations, and support partnerships with federal, state, local, Tribal governments, institutions of higher education, and the private sector to set program and technical requirements for future environmental biodetection programs.
Introduced January 23, 2025 by Dale Strong · Last progress March 12, 2025